ES2213732T3 - Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos. - Google Patents

Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.

Info

Publication number
ES2213732T3
ES2213732T3 ES02075838T ES02075838T ES2213732T3 ES 2213732 T3 ES2213732 T3 ES 2213732T3 ES 02075838 T ES02075838 T ES 02075838T ES 02075838 T ES02075838 T ES 02075838T ES 2213732 T3 ES2213732 T3 ES 2213732T3
Authority
ES
Spain
Prior art keywords
compounds
ciclohexil
fenil
substituted
esters derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES02075838T
Other languages
English (en)
Inventor
Castillo Nieto Juan Carlos Del
Freixa Maria Chalaux
Clotet Joan Huguet
Mancini Marisabel Mourelle
Ramon Amat Elisabet De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Vita SA
Original Assignee
Laboratorios Vita SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Vita SA filed Critical Laboratorios Vita SA
Application granted granted Critical
Publication of ES2213732T3 publication Critical patent/ES2213732T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/40—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings
    • C07C271/42—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/44—Esters of carbamic acids having oxygen atoms of carbamate groups bound to carbon atoms of six-membered aromatic rings with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to hydrogen atoms or to carbon atoms of unsubstituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/26—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C219/28—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C219/30—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton having amino groups bound to acyclic carbon atoms of the carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención se refiere a ésteres del O-desmetiltramadol o su derivado 1, 2-deshidratado. La actividad analgésica de estos compuestos ha resultado ser superior al Tramadol con una menor toxicidad y con una duración de acción más larga tras su administración por vía oral (Véase Figura 1). En particular, la presente invención describe y reivindica los productos de fórmula general (I), sus sales e isómeros ópticos, así como su procedimiento de obtención.
ES02075838T 1998-11-06 1999-11-04 Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos. Expired - Lifetime ES2213732T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES009802329A ES2141688B1 (es) 1998-11-06 1998-11-06 Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.

Publications (1)

Publication Number Publication Date
ES2213732T3 true ES2213732T3 (es) 2004-09-01

Family

ID=8305698

Family Applications (4)

Application Number Title Priority Date Filing Date
ES009802329A Expired - Fee Related ES2141688B1 (es) 1998-11-06 1998-11-06 Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
ES02075837T Expired - Lifetime ES2213731T3 (es) 1998-11-06 1999-11-04 Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
ES02075838T Expired - Lifetime ES2213732T3 (es) 1998-11-06 1999-11-04 Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
ES99953994T Expired - Lifetime ES2207298T3 (es) 1998-11-06 1999-11-04 Nuevos esteres derivados de compuestos fenil-ciclohexil substituidos.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ES009802329A Expired - Fee Related ES2141688B1 (es) 1998-11-06 1998-11-06 Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
ES02075837T Expired - Lifetime ES2213731T3 (es) 1998-11-06 1999-11-04 Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES99953994T Expired - Lifetime ES2207298T3 (es) 1998-11-06 1999-11-04 Nuevos esteres derivados de compuestos fenil-ciclohexil substituidos.

Country Status (39)

Country Link
US (1) US6455585B1 (es)
EP (3) EP1219623B1 (es)
JP (1) JP2002529442A (es)
KR (1) KR100453613B1 (es)
CN (1) CN1176902C (es)
AP (1) AP1222A (es)
AT (3) ATE257817T1 (es)
AU (1) AU755681B2 (es)
BG (1) BG105556A (es)
BR (1) BR9915727A (es)
CA (1) CA2349245A1 (es)
CR (1) CR6368A (es)
CU (1) CU23006A3 (es)
CZ (1) CZ20011500A3 (es)
DE (3) DE69914229T2 (es)
DK (3) DK1219594T3 (es)
EA (1) EA003742B1 (es)
EE (1) EE200100246A (es)
ES (4) ES2141688B1 (es)
GE (1) GEP20033116B (es)
HR (1) HRP20010412B1 (es)
HU (1) HUP0104218A3 (es)
ID (1) ID29017A (es)
IL (1) IL142592A0 (es)
IS (1) IS5934A (es)
MA (1) MA26765A1 (es)
MX (1) MXPA01004432A (es)
NO (1) NO20012234L (es)
NZ (1) NZ511739A (es)
OA (1) OA11672A (es)
PL (1) PL347492A1 (es)
PT (3) PT1127871E (es)
SI (3) SI1127871T1 (es)
SK (1) SK284068B6 (es)
TR (3) TR200200416T2 (es)
UA (1) UA59477C2 (es)
WO (1) WO2000027799A1 (es)
YU (1) YU29601A (es)
ZA (1) ZA200104026B (es)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2160534B1 (es) * 1999-12-30 2002-04-16 Vita Invest Sa Nuevos esteres derivados de (rr,ss)-2-hidroxibenzoato de 3-(2-dimetilaminometil-1-hidroxiciclohexil) fenilo.
DE10049483A1 (de) * 2000-09-29 2002-05-02 Gruenenthal Gmbh Substituierte 1-Aminobutan-3-ol-Derivate
US7776314B2 (en) 2002-06-17 2010-08-17 Grunenthal Gmbh Abuse-proofed dosage system
WO2004026291A1 (fr) * 2002-08-28 2004-04-01 Shuyi Zhang Formulations orales d'ibuprofene et de tramadol, methodes de preparation de ces dernieres
EP1908460A1 (de) 2002-11-22 2008-04-09 Grünenthal GmbH Verwendung von (1R,2R)-3-(2-Dimethylaminomethyl-cyclohexyl)-phenol zur Behandlung von Entzündungsschmerz
US20040248979A1 (en) * 2003-06-03 2004-12-09 Dynogen Pharmaceuticals, Inc. Method of treating lower urinary tract disorders
DE102004032051A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten, festen Darreichungsform
DE102005005446A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE10361596A1 (de) 2003-12-24 2005-09-29 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
US20070048228A1 (en) 2003-08-06 2007-03-01 Elisabeth Arkenau-Maric Abuse-proofed dosage form
US8075872B2 (en) 2003-08-06 2011-12-13 Gruenenthal Gmbh Abuse-proofed dosage form
DE10336400A1 (de) 2003-08-06 2005-03-24 Grünenthal GmbH Gegen Missbrauch gesicherte Darreichungsform
DE102004032049A1 (de) 2004-07-01 2006-01-19 Grünenthal GmbH Gegen Missbrauch gesicherte, orale Darreichungsform
DE102004034619A1 (de) * 2004-07-16 2006-02-23 Grünenthal GmbH Substituierte Aminoverbindungen als 5-HT/NA Uptakehemmer
DE102005005449A1 (de) 2005-02-04 2006-08-10 Grünenthal GmbH Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102007011485A1 (de) 2007-03-07 2008-09-11 Grünenthal GmbH Darreichungsform mit erschwertem Missbrauch
RU2493830C2 (ru) 2008-01-25 2013-09-27 Грюненталь Гмбх Лекарственная форма
RU2508092C2 (ru) 2008-05-09 2014-02-27 Грюненталь Гмбх Способ получения твердой лекарственной формы, в частности таблетки для фармацевтического применения, и способ получения прекурсора твердой лекарственной формы, в частности таблетки
BR112012001244A2 (pt) 2009-07-22 2020-12-08 Gruünenthal Gmbh Forma de dosagem resitente à adulteração, seu processo de produção, e embalagem contendo tal forma
US10080721B2 (en) 2009-07-22 2018-09-25 Gruenenthal Gmbh Hot-melt extruded pharmaceutical dosage form
EP2383255A1 (en) * 2010-04-28 2011-11-02 Lacer, S.A. New compounds, synthesis and use thereof in the treatment of pain
NZ607392A (en) 2010-09-02 2015-03-27 Gruenenthal Chemie Tamper resistant dosage form comprising inorganic salt
AU2011297892B2 (en) 2010-09-02 2014-05-29 Grunenthal Gmbh Tamper resistant dosage form comprising an anionic polymer
WO2012100423A1 (en) * 2011-01-27 2012-08-02 Eli Lilly And Company Analgesic compounds, methods, and formulations
EP2530072A1 (en) 2011-06-03 2012-12-05 Lacer, S.A. New compounds, synthesis and use thereof in the treatment of pain
US10702485B2 (en) 2011-07-09 2020-07-07 Syntrix Biosystems Inc. Compositions and methods for overcoming resistance to tramadol
CA2839126A1 (en) 2011-07-29 2013-02-07 Grunenthal Gmbh Tamper-resistant tablet providing immediate drug release
AR087360A1 (es) 2011-07-29 2014-03-19 Gruenenthal Gmbh Tableta a prueba de manipulacion que proporciona liberacion de farmaco inmediato
WO2013127831A1 (en) 2012-02-28 2013-09-06 Grünenthal GmbH Tamper-resistant dosage form comprising pharmacologically active compound and anionic polymer
LT2838512T (lt) 2012-04-18 2018-11-12 GrĆ¼nenthal GmbH Pažeidimui atspari ir dozės atpalaidavimo nuokrypiui atspari farmacinė vaisto forma
WO2013168005A2 (en) * 2012-05-10 2013-11-14 Mahesh Kandula Compositions and methods for the treatment of restless leg syndrome and fibromyalgia
US10064945B2 (en) 2012-05-11 2018-09-04 Gruenenthal Gmbh Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
CA2907950A1 (en) 2013-05-29 2014-12-04 Grunenthal Gmbh Tamper-resistant dosage form containing one or more particles
EP3003283A1 (en) 2013-05-29 2016-04-13 Grünenthal GmbH Tamper resistant dosage form with bimodal release profile
BR112016000194A8 (pt) 2013-07-12 2019-12-31 Gruenenthal Gmbh forma de dosagem resistente à violação contendo o polímero de acetato de etileno-vinila
CN105934241B (zh) 2013-11-26 2020-06-05 格吕伦塔尔有限公司 通过低温研磨制备粉末状药物组合物
MX2016014738A (es) 2014-05-12 2017-03-06 Gruenenthal Gmbh Formulacion en capsula de liberacion inmediata resistente a alteraciones que comprende tapentadol.
MX2017013637A (es) 2015-04-24 2018-03-08 Gruenenthal Gmbh Forma de dosificacion resistente a alteraciones con liberacion inmediata y resistencia contra la extraccion por solventes.
WO2017042325A1 (en) 2015-09-10 2017-03-16 Grünenthal GmbH Protecting oral overdose with abuse deterrent immediate release formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1199764B (de) * 1963-04-02 1965-09-02 Gruenenthal Chemie Verfahren zur Herstellung von basisch substituierten Phenolaethern
US3652589A (en) * 1967-07-27 1972-03-28 Gruenenthal Chemie 1-(m-substituted phenyl)-2-aminomethyl cyclohexanols
DE19525137C2 (de) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
DE19609847A1 (de) * 1996-03-13 1997-09-18 Gruenenthal Gmbh Dimethyl-(3-aryl-but-3-enyl)-aminverbindungen als pharmazeutische Wirkstoffe

Also Published As

Publication number Publication date
UA59477C2 (uk) 2003-09-15
ATE257837T1 (de) 2004-01-15
ATE249418T1 (de) 2003-09-15
ES2213731T3 (es) 2004-09-01
EA200100476A1 (ru) 2002-02-28
PT1219594E (pt) 2004-04-30
PT1127871E (pt) 2003-12-31
CU23006A3 (es) 2004-12-17
CN1176902C (zh) 2004-11-24
BR9915727A (pt) 2001-09-04
SK284068B6 (sk) 2004-09-08
CZ20011500A3 (cs) 2001-09-12
PT1219623E (pt) 2004-04-30
MXPA01004432A (es) 2002-09-18
WO2000027799A1 (es) 2000-05-18
KR100453613B1 (ko) 2004-10-20
NO20012234D0 (no) 2001-05-04
NO20012234L (no) 2001-05-04
SI1219623T1 (en) 2004-06-30
SI1127871T1 (en) 2004-02-29
BG105556A (en) 2001-12-29
DE69911235D1 (de) 2003-10-16
EP1219623B1 (en) 2004-01-14
AP1222A (en) 2003-11-06
ES2141688A1 (es) 2000-05-16
AU1047300A (en) 2000-05-29
GEP20033116B (en) 2003-11-25
ZA200104026B (en) 2002-05-17
HUP0104218A2 (hu) 2002-03-28
HRP20010412B1 (en) 2004-04-30
CN1325377A (zh) 2001-12-05
DE69914231D1 (de) 2004-02-19
CR6368A (es) 2002-04-08
US6455585B1 (en) 2002-09-24
YU29601A (sh) 2003-04-30
DK1219594T3 (da) 2004-04-19
IS5934A (is) 2001-05-03
EP1127871B1 (en) 2003-09-10
TR200200416T2 (tr) 2003-01-21
TR200200415T2 (tr) 2002-06-21
AU755681B2 (en) 2002-12-19
DK1219623T3 (da) 2004-04-19
EE200100246A (et) 2002-12-16
CA2349245A1 (en) 2000-05-18
PL347492A1 (en) 2002-04-08
IL142592A0 (en) 2002-03-10
JP2002529442A (ja) 2002-09-10
KR20010080942A (ko) 2001-08-25
EP1219594A1 (en) 2002-07-03
MA26765A1 (fr) 2004-12-20
DK1127871T3 (da) 2003-11-24
DE69914231T2 (de) 2004-11-11
NZ511739A (en) 2002-11-26
ID29017A (id) 2001-07-26
DE69911235T2 (de) 2004-07-01
ATE257817T1 (de) 2004-01-15
ES2207298T3 (es) 2004-05-16
OA11672A (en) 2005-01-12
EP1219623A1 (en) 2002-07-03
EP1127871A1 (en) 2001-08-29
SI1219594T1 (en) 2004-06-30
HRP20010412A2 (en) 2002-12-31
EA003742B1 (ru) 2003-08-28
DE69914229T2 (de) 2004-12-09
SK5842001A3 (en) 2001-12-03
TR200101160T2 (tr) 2002-01-21
ES2141688B1 (es) 2001-02-01
DE69914229D1 (de) 2004-02-19
EP1219594B1 (en) 2004-01-14
HUP0104218A3 (en) 2002-11-28

Similar Documents

Publication Publication Date Title
ES2213732T3 (es) Nuevos esteres derivados de compuestos fenil-ciclohexil sustituidos.
CR6643A (es) Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos
CR6616A (es) Nuevos derivados de biarileter utiles como inhibidores de la recaptacion de monoaminas
ECSP055533A (es) Compuestos de fenilsulfonamida sustituida inhibidores de la producción de beta-amiloide
AR039385A1 (es) Derivados de tioxantina como inhibidores de la mieloperoxidasa
CR7698A (es) Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos
DOP2001000170A (es) Derivados de tiofeno utiles como agentes anticancesoros
UY26839A1 (es) Productos de derivados de la 4 - fenil - piridina
ES2164920T3 (es) Nuevos derivados heterociclicos y uso medicinal de los mismos.
UY26782A1 (es) Derivados del benzotiazol
CU23167A3 (es) Inhibidores de la recaptacion de monoaminas para el tratamiento de trastornos del snc
ECSP034917A (es) Nuevos derivados de acido sulfonico
AR053989A1 (es) Compuestos espiro-hidantoina sustituidos con piridilo. composiciones farmaceuticas y procesos de obtencion.
PA8581201A1 (es) Nuevos derivados de tiazol
UY26847A1 (es) Derivados de la pirrolidina
ES2029879T3 (es) Procedimiento para producir derivados de aminas sustituidas.
ATE345135T1 (de) Tropan-derivate mit dopamin-wiederaufnahme-hemmer-wirkung für die behandlung von ischämischen erkrankungen
ES2173177T3 (es) Compuestos alcaloides indol diterpeno.
AR029479A1 (es) Derivados de flavonas, su procedimiento de preparacion, medicamento, composiciones farmaceuticas y utilizacion de dichos derivados para la preparacion de un medicamento
HUP0203118A2 (hu) Béta-diszubsztituált metalloproteáz inhibitorok, ezeket tartalmazó gyógyszerkészítmények és alkalmazásuk
UY26844A1 (es) Nuevos derivados de la pirrolidona
UY26845A1 (es) Derivados de la pirimidina
ES2157644T3 (es) Nuevos derivados aminados del 6,7,8,9-tetrahidro-ciclopenta-(a)-naftaleno y del 2,3-dihidro-ciclopenta-(e)-indeno, sus procedimientos de preparacion y las composiciones farmaceuticas que los contienen.
AR030373A1 (es) Profarmacos para el tratamiento de enfermedades relacionadas con el receptor del nmda
HN2002000354A (es) Sales de acido citrico de un compuesto terapeutico y composiciones farmaceuticas que la contienen